ERAP1 and colorectal carcinoma: The pharmacological inhibition of ERAP1 in the CT26 CRC mouse model using ERAAP (ERAP1 homolog in mice) inhibitor leucinthiol and ERAAP siRNA correlated with tumor regression [33,34].